Related Experiment Videos
Intralymphatic steroid therapy for lymphoedema: preliminary studies
Lymphology
|March 1, 1982
Summary
This study explored intralymphatic corticosteroid infusions to reduce lymph node fibrosis in primary lymphedema patients. Eight of 18 leg lymphedema patients showed clinical improvement, and both facial lymphedema patients benefited.
Area of Science:
- Vascular Medicine
- Dermatology
- Surgical Oncology
Background:
- Lymph node fibrosis is a key issue in primary lymphedema, obstructing lymph flow.
- This study investigates intralymphatic corticosteroid infusion as a treatment to mitigate fibrosis.
Observation:
- Twenty patients with primary lymphedema received intralymphatic infusions of Clobetasol propionate in Ultra-fluid Lipiodol.
- Eight of eighteen patients with lower limb lymphedema experienced clinical improvement over nine months.
- Both patients with facial lymphedema showed positive responses to the therapy.
Findings:
- Intralymphatic Clobetasol propionate infusion demonstrated potential in reducing lymphedema symptoms.
- Treatment efficacy may be linked to the patency of lymphatic vessels leading to lymph nodes.
Implications:
- This pilot study suggests a novel therapeutic approach for managing lymph node fibrosis in lymphedema.
- Further research is warranted to confirm efficacy and optimize intralymphatic corticosteroid delivery for lymphedema treatment.